Who is sponsoring NCT03778164?

NCT03778164 is sponsored by Hunter College of City University of New York.

What condition does NCT03778164 study?

NCT03778164 studies HIV Infections.

Is NCT03778164 still recruiting?

NCT03778164 is currently status unknown. Last updated 1 March 2023.

Last reviewed 2023-03-01 · How we verify

NCT03778164: FastTrack

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Prevention Systems to Reduce Disparities for High Priority Populations

Status unknown NA Last updated 1 March 2023

What this trial tests

NA trial testing Fast Track Partner Services-Sexual Health Intervention in HIV Infections in 1,150 participants. Status unknown.

Timeline

1 April 2021

Primary endpoint
31 July 2023

31 October 2023

Quick facts

Lead sponsor	Hunter College of City University of New York
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	1,150
Start date	1 April 2021
Primary completion	31 July 2023
Estimated completion	31 October 2023
Sites	1 location across United States

Drugs / interventions tested

Fast Track Partner Services-Sexual Health Intervention
Partner Services Standard of Care

Conditions studied

HIV Infections — all drugs for HIV Infections →

Sponsor

Hunter College of City University of New York

Who can join

18 and older, any sex, with HIV Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project collaborates with the New York City Department of Health and Mental Hygiene (NYC DOHMH) to develop and test a field-based comprehensive sexual health intervention for HIV-exposed contacts notified by its Partner Services (i.e., HIV contact tracing) program. The goal of the study is to develop and test the impact of this new intervention on improving rates of HIV testing, linkage to HIV prevention/care, and PrEP uptake among highest risk contacts recently exposed to HIV. We will conduct a 6-month pilot project, followed by a cross-sectional stepped wedge cluster randomized trial in which 12 clusters of NYC neighborhoods are exposed to the intervention sequentially, with three clusters moving from control to intervention every 6 months (n = 1150). Primary outcomes are HIV testing, timely PrEP/ARV uptake, and linkage to PrEP/HIV care. Secondary outcomes are STD testing and receipt of STD treatment (if indicated).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Reaching the second 90: the strategies for linkage to care and antiretroviral therapy initiation.
Bunda BA, Bassett IV. · · 2019 · cited 25× · PMID 31408009 · DOI 10.1097/coh.0000000000000579

Verify or expand the search:

Other recruiting trials for HIV Infections

Currently open trials in the same condition.

NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07202546 — A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · recruiting
NCT06694753 — Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall · Phase 1 · recruiting
NCT07235852 — Pilot Testing Into the Feasibility of the Developed Cognitive Behavioral Therapy Intervention · NA · recruiting
NCT06665646 — Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Ad · Phase 1 · recruiting

Other Hunter College of City University of New York trials

Trials by the same sponsor.

NCT06860932 — A Palliative Care Model Impact on Knowledge and Attitudes · NA · recruiting
NCT06505421 — Eccentric Exercise and Fatigue in Multiple Sclerosis · recruiting
NCT06126107 — Gain and Loss Framed Text Messaging to Reduce Drinking Among Older Adults · NA · completed
NCT06094855 — Effect of Cooling on Balance Performance in Multiple Sclerosis · recruiting
NCT05544578 — Korean Translation and Validation of the K-HEPI in NYC · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03778164 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hunter College of City University of New York
Last refreshed: 1 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03778164.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing